drugset / Trial / NCT00422955
Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.
RandomizedCrossoverDouble-blindTreatment
Summary
Fluid management study in patients with type 2 diabetes and autonomic neuropathy.
Timeline
- Start
- 2003-11
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | 4 mg | — |